The independent source for health policy research, polling, and news.
81 - 100 of 164 Results
Exclusive: The head of the National Institute of Allergy and Infectious Diseases says health workers âhave lived up to the oath they takeâ but says shortages of protective gear have contributed to excess deaths.
Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.
In his campaign, President Joe Biden promised to undo policies, particularly health policies, implemented by former President Donald Trump. Yet, despite immense executive power, reversing four years of action takes time and resources.
Scientists learned the wrong lesson from past outbreaks, but Dr. Anthony Fauci doesnât cast blame.
It's no worse than the flu, and other deadly disinformation about the coronavirus
In a new interview, the nation's top infectious disease expert tells us how to survive the coming months and describes how hard it is when people still insist the coronavirus outbreak is âfake news.â
Anthony Fauci is one of the nation's most trusted voices during public health emergencies. As the head of the National Institutes of Healthâs National Institute of Allergy and Infectious Diseases since 1984, Fauci has helped guide the nation through the HIV/AIDS epidemic and more recent outbreaks of Ebola and Zika. In this special episode of KHNâs âWhat the Health?â podcast, Fauci sits down with KHN Editor-in-Chief Elisabeth Rosenthal to talk about how to navigate the next phase of the coronavirus pandemic and what the incoming Biden administration should do first.
Drugmakers will walk away with massive profits, but much of the pioneering work on mRNA vaccines was done with government money.
If you or a loved one has COVID-19, hereâs what to consider before seeking experimental treatments.
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal governmentâs preeminent health agencies â the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health â are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHNâs Julie Rovner to discuss this and more. Plus, Rovner interviews KHNâs Elizabeth Lawrence about the latest KHN-NPR âBill of the Monthâ installment.
The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying theyâll opt instead to use the scarce resource to complete a clinical trial.
The nationâs top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.
About 70 college students are enrolled this summer in a program developed by San Francisco researchers and funded by the National Institutes of Health that allows them to explore the pandemicâs impact on communities facing health disparities.
This statement is taken from a video in which a group of doctors air unproven conspiracy theories about the coronavirus. Dr. Immanuel's claims were among the most inaccurate. And, before it was removed from social media platforms, thee video was viewed millions of times. President Donald Trump retweeted it.
The pandemic has given the National Institutes of Health an opportunity to show the value of its $1.5 billion âAll of Usâ research program. A major effort to make the platformâs database representative of America resulted in minorities making up more than half of its more than 270,000 volunteers.
Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.
President Donald Trumpâs proposed budget includes billions of dollars in health spending cuts, Congress gets back to work on surprise medical bills, and health care remains a top issue for the 2020 Democratic presidential candidates. Rep. Donna Shalala (D-Fla.), a former Health and Human Services secretary, joins the panel at a special taping before a live audience in Washington, D.C. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico join KHNâs Julie Rovner to discuss these issues and more.
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drugâs approval, many doctors are wary.
The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.
Š 2026 KFF